Literature DB >> 6020703

A semiautomatic one-stage factor 8 assay with a commercially prepared standard.

J V Simone, J Vanderheiden, C F Abildgaard.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 6020703

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  13 in total

Review 1.  Molecular cytogenetic analysis of a familial 8p23.1 deletion associated with minimal dysmorphic features, seizures, and mild mental retardation.

Authors:  M J Pettenati; N Rao; C Johnson; R Hayworth; K Crandall; O Huff; I T Thomas
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

2.  Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

Authors:  Veronica H Flood; Pamela A Christopherson; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Daniel B Bellissimo; Rupa A Udani; Mahua Dasgupta; Raymond G Hoffmann; Margaret V Ragni; Amy D Shapiro; Jeanne M Lusher; Steven R Lentz; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Marilyn J Manco-Johnson; Ralph A Gruppo; Lisa N Boggio; Kate T Montgomery; Anne C Goodeve; Paula D James; David Lillicrap; Ian R Peake; Robert R Montgomery
Journal:  Blood       Date:  2016-02-09       Impact factor: 22.113

3.  In vitro inhibition of platelet function and coagulation by pentamidine isethionate.

Authors:  S J Kempin; C W Jackson; C C Edwards
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

4.  Mechanism and modification of rejection of heterografts between divergent species.

Authors:  G R Giles; H J Boehmig; J Lilly; H Amemiya; H Takagi; A J Coburg; W E Hathaway; C B Wilson; F J Dixon; T E Starzl
Journal:  Transplant Proc       Date:  1970-12       Impact factor: 1.066

5.  Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements.

Authors:  H J Boehmig; G R Giles; H Amemiya; C B Wilson; A J Coburg; E Genton; D L Bunch; F J Dixon; T E Starzl
Journal:  Transplant Proc       Date:  1971-06       Impact factor: 1.066

6.  Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.

Authors:  H R Gralnick; B S Coller; Y Sultan
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

7.  Comparison between the polymyxins and gentamicin in preventing endotoxin-induced intravascular coagulation and leukopenia.

Authors:  J J Corrigan; B M Bell
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

8.  Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.

Authors:  J Koutts; P N Walsh; E F Plow; J W Fenton; B N Bouma; T S Zimmerman
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

9.  Studies on the purification and characterization of human factor 8.

Authors:  S L Marchesi; N R Shulman; H R Gralnick
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

10.  Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.

Authors:  H R Gralnick; H M Givelber; J R Shainoff; J S Finlayson
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.